ELIQUENT Life Sciences Announces Expanded Platform of Due Diligence Solutions
ELIQUENT Life Sciences, a global regulatory consulting firm, today announced an expanded portfolio of due diligence services tailored to the unique needs of the life sciences industry.
- ELIQUENT Life Sciences, a global regulatory consulting firm, today announced an expanded portfolio of due diligence services tailored to the unique needs of the life sciences industry.
- A trusted partner to life science innovators, ELIQUENT’s expanded due diligence platform leverages the unmatched experience and robust institutional knowledge of the firm’s regulatory experts to empower decisions and drive value.
- “ELIQUENT is built on the powerful alliance of six global life science consultancies – this fusion of capabilities and expertise created a best-in-class solution for life science innovators.
- ELIQUENT’s expanded platform of due diligence solutions delivers the same valuable insight for companies considering life sciences transactions,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences.